COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab.

PLoS One · 2021 · PMC8376065 · PMID 34411149

Europe PMC DOI

hedged sentence

0.0790

closest p · 1.6× alpha

0.0790

boldest claim

The sentences

showed a trendp = 0.079so close (0.05 < p ≤ 0.1)

Long-term incubation with COVID19 patient serum also had effects on cellular arrhythmogenic potential: Ca 2+ waves showed a trend to occur more often upon incubation with patient serum as compared to control (0.22 ± 0.04 vs 0.37 ± 0.04 (control vs patient), waves/sec, n = 32 vs 49, p = 0.079) and spontaneous Ca 2+ release events (i.e.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.